Vanda Pharmaceuticals Inc

General

Total Cases41

Active Cases8

Patents117

CourtsD. Delaware D. New Jersey S.D. Florida

TypeOperating Company

Elite Ratings

--

vandapharma.com

vanda-pharmaceuticals

vanda-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L3

A

PTAB

L1

B

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/17/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	Pro Hac Vice Attorney William B. Coblentz, Aaron S. Lukas, Keri L. Schaubert for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 09/17/2024)
09/17/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	SO ORDERED, re [12] Motion for Pro Hac Vice Appearance of Attorney W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Ordered by Judge Jennifer L. Hall on 9/17/2024. (ceg) (Entered: 09/17/2024)
09/16/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	Pro Hac Vice Fee - Credit Card Payment received for W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert. ( re [12] MOTION for Pro Hac Vice Appearance of Attorney W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert )( Payment of $ 150, receipt number ADEDC-4499449).(Ekiner, Kaan) (Entered: 09/16/2024)
09/16/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	MOTION for Pro Hac Vice Appearance of Attorney W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ekiner, Kaan) (Entered: 09/16/2024)
09/16/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) the parties' positions regarding any disputes in the proposed Scheduling Order and (b) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024) ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) the parties' positions regarding any disputes in the proposed Scheduling Order and (b) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024)
09/13/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	ANSWER to [1] Complaint , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Ekiner, Kaan) (Entered: 09/13/2024)
09/13/24	Vanda Pharmaceuticals Inc v. Teva Pharmaceuticals USA Inc 1:23-CV-00152 ( D. DE )	PROPOSED Scheduling Order, by Vanda Pharmaceuticals Inc. (Silver, Daniel) Modified on 9/13/2024 (ceg). (Entered: 09/13/2024)
09/13/24	Vanda Pharmaceuticals Inc v. Apotex Inc 1:23-CV-00153 ( D. DE )	PROPOSED Scheduling Order, by Vanda Pharmaceuticals Inc. (Silver, Daniel) Modified on 9/13/2024 (ceg). (Entered: 09/13/2024)
09/13/24	Vanda Pharmaceuticals Inc v. MSN Pharmaceuticals Inc 1:24-CV-00815 ( D. DE )	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ekiner, Kaan) (Entered: 09/13/2024)
09/06/24	Vanda Pharmaceuticals Inc v. Teva Pharmaceuticals USA Inc 1:23-CV-00152 ( D. DE )	NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 09/06/2024)